Fosfomycin Tromethamine Cas 78964-85-9

Fosfomycin Tromethamine (CAS 78964-85-9) Ultimate Guide

Table of Contents

• 1. Product Specifications & Comparative Analysis
• 2. Clinical Applications & Therapeutic Uses
• 3. Administration Guidelines
• 4. Clinical Case Studies
• 5. Industry Adoption Case Histories
• 6. Professional Consultation & Inquiry

1. Product Specifications & Comparative Analysis

2. Clinical Applications & Therapeutic Uses

Primary Medical Indications:

• Uncomplicated UTIs (Single-dose therapy)
• Prostatitis management
• Surgical prophylaxis

Emerging Applications:

• Multidrug-resistant infection protocols
• Pediatric pyelonephritis off-label use

3. Administration Guidelines

4. Clinical Case Studies

Case 1: MDR E.coli Cystitis

Patient: 34F with diabetes
Outcome: Symptom resolution within 48hrs
Resistance Profile: Resistant to 3rd-gen cephalosporins

Case 2: Recurrent Pyelonephritis

Patient: 58M with prostate enlargement
Regimen: 3g q48h × 3 doses
Follow-up: 6-month infection-free period

5. Industry Adoption Case Histories

Hospital Network Implementation

Client: Southeast Asia Medical Consortium
Usage: 12,000 doses/year since 2021
Impact: 38% reduction in extended-spectrum β-lactamase cases

Pharmaceutical Research Application

Client: European Antibiotic Research Group
Study: Synergy with carbapenems (n=450 patients)
Finding: 72% enhanced bactericidal activity

6. Professional Consultation & Inquiry

For technical specifications, clinical data packages, or bulk procurement:

• Email: info@vivalr.com
• Tel: (86) 15866781826

Request full pharmacopeia documentation or stability studies:

[Submit API Inquiry Form]